B-Disease	0	8	Diabetic
I-Disease	9	20	Retinopathy
O	21	29	Severity
O	30	33	and
B-Symptom	34	44	Peripheral
I-Symptom	45	52	Lesions
O	53	56	Are
O	57	67	Associated
O	68	72	with
B-Symptom	73	85	Nonperfusion
O	86	88	on
B-Diagnostic_tool	89	98	Ultrawide
I-Diagnostic_tool	99	104	Field
I-Diagnostic_tool	105	116	Angiography
O	116	117	.

O	119	121	To
O	122	128	assess
O	129	136	whether
O	137	140	the
O	141	149	presence
O	150	152	of
B-Symptom	153	163	peripheral
I-Symptom	164	176	nonperfusion
O	177	179	on
B-Diagnostic_tool	180	189	ultrawide
I-Diagnostic_tool	190	195	field
I-Diagnostic_tool	196	197	(
I-Diagnostic_tool	197	200	UWF
I-Diagnostic_tool	200	201	)
I-Diagnostic_tool	202	213	fluorescein
I-Diagnostic_tool	214	225	angiography
O	226	227	(
B-Diagnostic_tool	227	229	FA
O	229	230	)
O	231	233	is
O	234	244	associated
O	245	249	with
B-Disease	250	258	diabetic
I-Disease	259	270	retinopathy
O	271	272	(
B-Disease	272	274	DR
O	274	275	)
O	276	284	severity
O	285	288	and
O	289	292	the
O	293	301	presence
O	302	304	of
O	305	318	predominantly
B-Symptom	319	329	peripheral
I-Symptom	330	337	lesions
O	338	339	(
B-Symptom	339	343	PPLs
O	343	344	)
O	344	345	.

O	346	352	Single
O	352	353	-
O	353	357	site
O	357	358	,
O	359	364	cross
O	364	365	-
O	365	374	sectional
O	374	375	,
O	376	389	retrospective
O	390	395	study
O	395	396	.

O	397	402	Sixty
O	402	403	-
O	403	408	eight
B-Anatomy	409	413	eyes
O	414	416	of
O	417	419	37
B-Disease	420	428	diabetic
O	429	437	subjects
O	438	442	with
O	443	445	or
O	446	453	without
B-Disease	454	456	DR
O	457	460	and
O	461	463	no
O	464	471	history
O	472	474	of
O	475	480	prior
O	481	491	panretinal
O	492	497	laser
O	498	514	photocoagulation
O	514	515	.

O	516	520	Both
B-Diagnostic_tool	521	524	200
I-Diagnostic_tool	524	525	Â°
I-Diagnostic_tool	526	529	UWF
I-Diagnostic_tool	530	536	images
O	537	540	and
B-Diagnostic_tool	541	544	UWF
I-Diagnostic_tool	545	547	FA
I-Diagnostic_tool	548	554	images
O	555	559	were
O	560	568	acquired
O	569	571	at
O	572	575	the
O	576	580	same
O	581	586	visit
O	586	587	.

B-Classification_system	588	593	Early
I-Classification_system	594	603	Treatment
I-Classification_system	604	612	Diabetic
I-Classification_system	613	624	Retinopathy
I-Classification_system	625	630	Study
O	631	632	(
B-Classification_system	632	637	ETDRS
O	637	638	)
O	639	648	templates
O	649	653	were
O	654	662	overlaid
O	663	672	digitally
O	673	678	based
O	679	681	on
B-Anatomy	682	686	disc
O	687	690	and
B-Anatomy	691	697	macula
O	698	706	location
O	707	711	onto
B-Diagnostic_tool	712	729	stereographically
I-Diagnostic_tool	730	739	projected
I-Diagnostic_tool	740	743	UWF
I-Diagnostic_tool	744	750	images
O	750	751	.

O	752	758	Images
O	759	763	were
O	764	773	evaluated
O	774	777	for
O	778	781	the
O	782	790	presence
O	791	793	of
B-Symptom	794	798	PPLs
O	798	799	,
O	800	807	defined
O	808	810	as
O	811	815	more
O	816	820	than
O	821	823	50
O	823	824	%
O	825	827	of
O	828	831	the
O	832	838	graded
O	839	845	lesion
O	846	853	located
O	854	861	outside
O	862	865	the
B-Classification_system	866	871	ETDRS
O	872	877	field
O	878	880	in
O	881	885	each
O	886	888	of
O	889	892	the
O	893	894	5
O	895	903	extended
O	904	910	fields
O	910	911	.

O	912	915	The
B-Diagnostic_tool	916	919	UWF
I-Diagnostic_tool	919	920	-
I-Diagnostic_tool	920	922	FA
I-Diagnostic_tool	923	929	images
O	930	934	were
O	935	944	evaluated
O	945	947	by
O	948	949	2
O	950	956	masked
O	956	957	,
O	958	969	independent
O	970	977	graders
O	978	981	for
O	982	988	extent
O	989	991	of
B-Characteristic	992	999	retinal
I-Characteristic	1000	1012	nonperfusion
I-Characteristic	1013	1017	area
O	1018	1019	(
B-Characteristic	1019	1022	NPA
O	1022	1023	)
O	1024	1027	and
B-Characteristic	1028	1040	nonperfusion
I-Characteristic	1041	1046	index
O	1047	1048	(
B-Characteristic	1048	1051	NPI
O	1051	1052	;
O	1053	1064	nonperfused
O	1064	1065	/
O	1065	1070	total
O	1071	1079	gradable
O	1080	1084	area
O	1084	1085	)
O	1085	1086	.

O	1087	1098	Association
O	1099	1101	of
B-Characteristic	1102	1105	NPA
O	1106	1109	and
B-Characteristic	1110	1113	NPI
O	1114	1118	with
B-Disease	1119	1121	DR
O	1122	1130	severity
O	1131	1134	and
O	1135	1143	presence
O	1144	1146	of
B-Symptom	1147	1151	PPLs
O	1151	1152	.

O	1153	1165	Distribution
O	1166	1168	of
B-Disease	1169	1171	DR
O	1172	1180	severity
O	1181	1184	was
O	1185	1187	as
O	1188	1195	follows
O	1195	1196	:
O	1197	1199	no
B-Disease	1200	1202	DR
O	1202	1203	,
O	1204	1205	8
O	1205	1206	.
O	1206	1207	8
O	1207	1208	%
O	1209	1213	eyes
O	1213	1214	;
B-Disease	1215	1219	mild
I-Disease	1220	1236	nonproliferative
I-Disease	1237	1239	DR
O	1240	1241	(
B-Disease	1241	1245	NPDR
O	1245	1246	)
O	1246	1247	,
O	1248	1250	17
O	1250	1251	.
O	1251	1252	6
O	1252	1253	%
O	1253	1254	;
B-Disease	1255	1263	moderate
I-Disease	1264	1268	NPDR
O	1268	1269	,
O	1270	1272	32
O	1272	1273	.
O	1273	1274	4
O	1274	1275	%
O	1275	1276	;
B-Disease	1277	1283	severe
I-Disease	1284	1288	NPDR
O	1288	1289	,
O	1290	1292	17
O	1292	1293	.
O	1293	1294	6
O	1294	1295	%
O	1295	1296	;
B-Disease	1297	1310	proliferative
I-Disease	1311	1313	DR
O	1314	1315	(
B-Disease	1315	1318	PDR
O	1318	1319	)
O	1319	1320	,
O	1321	1323	19
O	1323	1324	.
O	1324	1325	1
O	1325	1326	%
O	1326	1327	;
O	1328	1331	and
B-Disease	1332	1336	high
I-Disease	1336	1337	-
I-Disease	1337	1341	risk
I-Disease	1342	1345	PDR
O	1345	1346	,
O	1347	1348	4
O	1348	1349	.
O	1349	1350	4
O	1350	1351	%
O	1351	1352	;
O	1353	1357	with
B-Symptom	1358	1361	PPL
O	1362	1369	present
O	1370	1372	in
O	1373	1375	61
O	1375	1376	.
O	1376	1377	8
O	1377	1378	%
O	1378	1379	.

O	1380	1385	There
O	1386	1389	was
O	1390	1396	strong
O	1397	1408	intragrader
O	1409	1410	(
O	1410	1411	r
O	1412	1413	=
O	1414	1415	0
O	1415	1416	.
O	1416	1418	95
O	1418	1419	)
O	1420	1423	and
O	1424	1435	intergrader
O	1436	1437	(
O	1437	1438	r
O	1439	1440	=
O	1441	1442	0
O	1442	1443	.
O	1443	1445	86
O	1445	1446	)
O	1447	1456	agreement
O	1457	1460	for
B-Characteristic	1461	1464	NPA
O	1464	1465	.

O	1466	1474	Presence
O	1475	1477	of
B-Symptom	1478	1482	PPLs
O	1483	1486	was
O	1487	1497	associated
O	1498	1502	with
O	1503	1512	increased
B-Characteristic	1513	1516	NPA
O	1517	1518	(
O	1518	1521	191
O	1521	1522	.
O	1522	1523	8
O	1524	1526	mm
O	1526	1527	(
O	1527	1528	2
O	1528	1529	)
O	1530	1532	vs
O	1532	1533	.
O	1534	1537	306
O	1537	1538	.
O	1538	1539	1
O	1540	1542	mm
O	1542	1543	(
O	1543	1544	2
O	1544	1545	)
O	1545	1546	;
O	1547	1548	P
O	1549	1550	=
O	1551	1552	0
O	1552	1553	.
O	1553	1557	0019
O	1557	1558	)
O	1559	1562	and
B-Characteristic	1563	1566	NPI
O	1567	1568	(
O	1568	1569	0
O	1569	1570	.
O	1570	1572	25
O	1573	1575	vs
O	1575	1576	.
O	1577	1578	0
O	1578	1579	.
O	1579	1581	43
O	1581	1582	;
O	1583	1584	P
O	1585	1586	=
O	1587	1588	0
O	1588	1589	.
O	1589	1593	0003
O	1593	1594	)
O	1594	1595	.

O	1596	1601	These
O	1602	1615	relationships
O	1616	1624	remained
O	1625	1636	significant
O	1637	1642	after
O	1643	1652	adjusting
O	1653	1656	for
B-Disease	1657	1659	DR
O	1660	1668	severity
O	1669	1672	and
B-Characteristic	1673	1681	diabetes
I-Characteristic	1682	1690	duration
O	1690	1691	.

O	1692	1694	In
B-Anatomy	1695	1699	eyes
O	1700	1707	without
B-Disease	1708	1711	PDR
O	1712	1713	(
O	1713	1714	n
O	1715	1716	=
O	1717	1719	52
O	1719	1720	)
O	1720	1721	,
O	1722	1732	increasing
B-Characteristic	1733	1736	NPA
O	1737	1740	and
B-Characteristic	1741	1744	NPI
O	1745	1748	was
O	1749	1759	associated
O	1760	1764	with
O	1765	1774	worsening
B-Disease	1775	1777	DR
O	1778	1779	(
B-Characteristic	1779	1782	NPA
O	1782	1783	,
O	1784	1785	P
O	1786	1787	=
O	1788	1789	0
O	1789	1790	.
O	1790	1793	001
O	1793	1794	;
O	1795	1798	NPI
O	1798	1799	,
O	1800	1801	P
O	1802	1803	=
O	1804	1805	0
O	1805	1806	.
O	1806	1810	0003
O	1810	1811	)
O	1811	1812	.

B-Characteristic	1813	1816	NPA
O	1817	1820	and
B-Characteristic	1821	1824	NPI
O	1825	1829	were
O	1830	1833	not
O	1834	1844	associated
O	1845	1849	with
B-Disease	1850	1860	clinically
I-Disease	1861	1872	significant
I-Disease	1873	1880	macular
I-Disease	1881	1886	edema
O	1887	1888	(
B-Characteristic	1888	1891	NPA
O	1891	1892	,
O	1893	1894	P
O	1895	1896	=
O	1897	1898	0
O	1898	1899	.
O	1899	1901	99
O	1901	1902	;
O	1903	1906	NPI
O	1906	1907	,
O	1908	1909	P
O	1910	1911	=
O	1912	1913	0
O	1913	1914	.
O	1914	1916	67
O	1916	1917	)
O	1917	1918	,
O	1919	1922	nor
O	1923	1933	correlated
O	1934	1938	with
B-Characteristic	1939	1945	visual
I-Characteristic	1946	1952	acuity
O	1953	1954	(
B-Characteristic	1954	1957	NPA
O	1957	1958	,
O	1959	1960	r
O	1961	1962	=
O	1963	1964	0
O	1964	1965	.
O	1965	1967	14
O	1967	1968	,
O	1969	1970	P
O	1971	1972	=
O	1973	1974	0
O	1974	1975	.
O	1975	1977	23
O	1977	1978	;
B-Characteristic	1979	1982	NPI
O	1982	1983	,
O	1984	1985	r
O	1986	1987	=
O	1988	1989	0
O	1989	1990	.
O	1990	1992	24
O	1992	1993	,
O	1994	1995	P
O	1996	1997	=
O	1998	1999	0
O	1999	2000	.
O	2000	2002	05
O	2002	2003	)
O	2003	2004	.

O	2005	2014	Following
O	2015	2016	a
O	2017	2029	standardized
O	2030	2038	protocol
O	2038	2039	,
O	2040	2043	the
O	2044	2054	evaluation
O	2055	2057	of
B-Diagnostic_tool	2058	2061	UWF
I-Diagnostic_tool	2062	2064	FA
O	2065	2068	for
B-Characteristic	2069	2072	NPA
O	2073	2076	and
B-Characteristic	2077	2080	NPI
O	2081	2083	is
O	2084	2096	reproducible
O	2096	2097	.

O	2098	2102	Both
O	2103	2113	parameters
O	2114	2117	are
O	2118	2128	correlated
O	2129	2135	highly
O	2136	2140	with
O	2141	2144	the
O	2145	2153	presence
O	2154	2156	of
B-Symptom	2157	2161	PPLs
O	2162	2165	and
B-Disease	2166	2168	DR
O	2169	2177	severity
O	2177	2178	.

O	2179	2184	Given
O	2185	2189	that
O	2190	2193	the
O	2194	2202	presence
O	2203	2206	and
O	2207	2213	extent
O	2214	2216	of
B-Symptom	2217	2221	PPLs
O	2222	2226	have
O	2227	2231	been
O	2232	2242	associated
O	2243	2247	with
O	2248	2257	increased
O	2258	2263	risks
O	2264	2266	of
B-Disease	2267	2269	DR
O	2270	2281	progression
O	2281	2282	,
O	2283	2286	the
O	2287	2295	clinical
O	2296	2310	identification
O	2311	2313	of
B-Symptom	2314	2318	PPLs
O	2319	2322	may
O	2323	2330	reflect
O	2331	2338	closely
O	2339	2342	the
O	2343	2349	extent
O	2350	2352	of
B-Symptom	2353	2365	nonperfusion
O	2366	2369	and
B-Disease	2370	2378	ischemia
O	2378	2379	,
O	2380	2384	thus
O	2385	2395	accounting
O	2396	2399	for
O	2400	2403	the
O	2404	2413	increased
O	2414	2418	risk
O	2419	2421	of
O	2422	2433	progression
O	2433	2434	.
